Contraception

Journal

Publication Venue For

  • A comparative analysis of documented contraceptive use among women aged 18–30 living with and without HIV in Alabama.  100:275-278. 2019
  • Rebound of medication abortion in Texas following updated mifepristone label.  99:278-280. 2019
  • Counseling and referrals for women with unplanned pregnancies at publicly funded family planning organizations in Texas.  99:48-51. 2019
  • Is a lower-dose, subcutaneous contraceptive injectable containing depot medroxyprogesterone acetate likely to impact women's risk of HIV?.  97:191-197. 2018
  • Does information about abortion safety affect Texas voters’ opinions about restrictive laws? A randomized study.  96:381-387. 2017
  • Prostate-specific antigen concentration in vaginal fluid after exposure to semen.  96:336-343. 2017
  • Erratum: Corrigendum to “Effect of progestins on immunity: medroxyprogesterone but not norethisterone or levonorgestrel suppresses the function of T cells and pDCs” (Contraception (2014) 90(2) (123–129) (S0010782414000535) (10.1016/j.contraception.2014.02.006)).  94:578. 2016
  • Women's experiences seeking abortion care shortly after the closure of clinics due to a restrictive law in Texas.  93:292-297. 2016
  • Complications from first-trimester aspiration abortion: a systematic review of the literature.  92:422-438. 2015
  • Continuing pregnancy after mifepristone and "reversal" of first-trimester medical abortion: A systematic review.  92:206-211. 2015
  • The influence of partnership on contraceptive use among HIV-infected women accessing antiretroviral therapy in rural Uganda.  92:152-159. 2015
  • Change in abortion services after implementation of a restrictive lawin Texas.  90:496-501. 2014
  • Unmet demand for highly effective postpartum contraception in Texas.  90:488-495. 2014
  • The public health threat of anti-abortion legislation.  89:73-74. 2014
  • Effect of progestins on immunity: Medroxyprogesterone but not norethisterone or levonorgestrel suppresses the function of T cells and pDCs.  90:123-129. 2014
  • Reconsidering racial/ethnic differences in sterilization in the United States.  89:550-556. 2014
  • Variation in postpartum contraceptive method use: Results from the Pregnancy Risk Assessment Monitoring System (PRAMS).  89:57-62. 2014
  • Reproductive health preventive screening among clinic vs. over-the-counter oral contraceptive users.  86:376-382. 2012
  • Contraindications to progestin-only oral contraceptive pills among reproductive-aged women.  86:199-203. 2012
  • Revival of the intrauterine device: Increased insertions among US women with employer-sponsored insurance, 2002-2008.  85:155-159. 2012
  • Incidence of sexually transmitted infections among HIV-infected women using depot medroxyprogesterone acetate contraception.  78:125-130. 2008
  • Contraceptive knowledge and use among low-income Hispanic immigrant women and non-Hispanic women.  77:270-275. 2008
  • Acceptability of five nonoxynol-9 spermicides.  71:438-442. 2005
  • Success with oral contraceptives: A pilot study.  69:413-418. 2004
  • Safety and acceptability of a baggy latex condom.  61:217-223. 2000
  • Prostate-specific antigen in vaginal fluid as a biologic marker of condom failure.  59:195-201. 1999
  • Contraceptive female sterilization in Alabama: A replication of the WHO study.  43:325-333. 1991
  • International Standard Serial Number (issn)

  • 0010-7824
  • Electronic International Standard Serial Number (eissn)

  • 1879-0518